171 related articles for article (PubMed ID: 36035311)
1. Identification and Validation of Prognostic Markers for Lung Squamous Cell Carcinoma Associated with Chronic Obstructive Pulmonary Disease.
Li Z; Xu D; Jing J; Wang J; Jiang M; Li F
J Oncol; 2022; 2022():4254195. PubMed ID: 36035311
[TBL] [Abstract][Full Text] [Related]
2. Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD.
Miao TW; Du LY; Xiao W; Mao B; Wang Y; Fu JJ
Front Oncol; 2021; 11():600243. PubMed ID: 33791201
[No Abstract] [Full Text] [Related]
3. Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma.
Zhang C; Huang Y; Fang C; Liang Y; Jiang D; Li J; Ma H; Jiang W; Feng Y
Cancer Biomark; 2023; 36(4):313-326. PubMed ID: 36938730
[TBL] [Abstract][Full Text] [Related]
4. Multiple microarray analyses identify key genes associated with the development of Non-Small Cell Lung Cancer from Chronic Obstructive Pulmonary Disease.
Zhang L; Chen J; Yang H; Pan C; Li H; Luo Y; Cheng T
J Cancer; 2021; 12(4):996-1010. PubMed ID: 33442399
[No Abstract] [Full Text] [Related]
5. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma.
Lin L; Zhang W
Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
7. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
9. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
10. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Wang K; Li Y; Wang J; Chen R; Li J
Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
[TBL] [Abstract][Full Text] [Related]
11. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
12. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
Ma H; Tong L; Zhang Q; Chang W; Li F
Biomed Res Int; 2020; 2020():6427483. PubMed ID: 32596344
[TBL] [Abstract][Full Text] [Related]
13. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
14. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
17. A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.
Shen Y; Huang Q; Zhang Y; Hsueh CY; Zhou L
Cancer Cell Int; 2022 Jul; 22(1):226. PubMed ID: 35804447
[TBL] [Abstract][Full Text] [Related]
18. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
19. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
20. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]